The drug developed by Moscow's Gamaleya Institute and the Russian Direct Investment Fund may be approved for civilian use within three to seven days of registration by regulators, according to a person familiar with the process, who asked not to be identified because the information isn't public, according to a Bloomberg report. The Ministry of Health will decide whether the vaccine is effective on the basis of the results of the tests reported by Interfax.
"This gives us confidence that we can test a single-shot vaccine in this epidemic and learn whether it has a protective effect in humans", Dr Paul Stoffels, J&J's chief scientific officer, told Reuters in a telephone interview.
The pharmaceutical giant Johnson & Johnson took a step forward with its COVID-19 vaccine candidate Thursday, releasing promising data after testing on monkeys and at the same time announcing the start of clinical testing on humans.
Fauci, who was asked during a Congressional hearing whether the U.S. could make use of Chinese or Russian vaccines if they arrived first, indicated that was unlikely.More news: Britain secures 60m doses of Sanofi/GSK coronavirus vaccine
The launch of the Sputnik satellite in 1957 saw the Soviet Union beat the United States in the first leg of the space race.
"Now we will see which categories will get the vaccine first".
Shattock said he was optimistic the Imperial vaccine would work, but must await the scientific data from the trial.
In recent months, Russian Federation has rushed to develop a vaccine against the coronavirus.More news: Kim Kardashian Is ‘Torn’ Over Divorcing Kanye West
The US government is backing J&J's vaccine effort with $456 million in funding as part of a spending spree aimed at speeding production of a vaccine to end the pandemic, which has infected millions and killed more than 660,000 people.
AN Australian COVID-19 vaccine is slated to begin its second phase of testing in September after it was found to be safe and generated immune response in phase 1.
Although other companies are already enrolling patients in Phase 3 trials, vaccine experts say society will need more than one successful vaccine to ensure everyone has the chance to be immunized against the virus that causes COVID-19.
Mr Dmitriev, a close ally of President Putin, has also said that he and his family have tried the vaccine.More news: Boris Johnson postpones further easing of lockdown measures
Accordingly, Russia's vaccine is yet to complete its second phase.